Narrative Update • Jun 26
Have your own idea? Try our Stock Screener
U.K. (FTSE) Clinical Research and Equipment Industry Analysis
UpdatedJul 12, 2026
DataAggregated Company Financials
Companies7
- 7D-0.4%
- 3M9.3%
- 1Y-17.0%
- YTDn/a
Last week, the Clinical Research and Equipment industry hasn't moved much but IXICO is up 12% in that time. As for the longer term, the industry has declined 17% in the last year. As for the next few years, earnings are expected to grow by 56% per annum.
Industry Valuation and Performance
Has the U.K. Clinical Research and Equipment Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Mon, 13 Jul 2026 | UK£1.4b | UK£323.1m | -UK£164,731,254.00 | 1243.9x | -8.4x | 4.3x |
| Wed, 10 Jun 2026 | UK£1.5b | UK£323.0m | -UK£166,018,254.00 | 1248.2x | -8.8x | 4.5x |
| Fri, 08 May 2026 | UK£1.3b | UK£318.2m | -UK£167,469,254.00 | n/a | -8x | 4.2x |
| Sun, 05 Apr 2026 | UK£1.4b | UK£323.0m | -UK£156,192,254.00 | 8.2x | -8.8x | 4.2x |
| Tue, 03 Mar 2026 | UK£1.5b | UK£304.7m | -UK£159,511,254.00 | 10.9x | -9.5x | 5x |
| Thu, 29 Jan 2026 | UK£1.8b | UK£304.6m | -UK£159,441,254.00 | 7.7x | -11.3x | 5.9x |
| Sat, 27 Dec 2025 | UK£1.4b | UK£304.6m | -UK£159,441,254.00 | 8.8x | -9x | 4.7x |
| Mon, 24 Nov 2025 | UK£1.5b | UK£304.3m | -UK£163,156,254.00 | 7.5x | -9.2x | 4.9x |
| Wed, 22 Oct 2025 | UK£1.6b | UK£304.3m | -UK£163,156,254.00 | 9x | -9.7x | 5.2x |
| Fri, 19 Sep 2025 | UK£1.8b | UK£313.5m | -UK£158,190,352.00 | 6.2x | -11.3x | 5.7x |
| Sun, 17 Aug 2025 | UK£2.3b | UK£291.9m | -UK£160,968,352.00 | 6.5x | -14x | 7.7x |
| Tue, 15 Jul 2025 | UK£1.7b | UK£291.9m | -UK£160,968,352.00 | 6.4x | -10.3x | 5.7x |
| Thu, 12 Jun 2025 | UK£1.6b | UK£319.4m | -UK£190,810,117.60 | 7.6x | -8.4x | 5x |
| Sat, 10 May 2025 | UK£1.7b | UK£313.2m | -UK£192,933,253.70 | 11.2x | -8.7x | 5.4x |
| Mon, 07 Apr 2025 | UK£1.4b | UK£315.9m | -UK£186,638,286.55 | 5.7x | -7.7x | 4.5x |
| Wed, 05 Mar 2025 | UK£1.4b | UK£306.2m | -UK£195,386,130.24 | 6.7x | -7.3x | 4.6x |
| Fri, 31 Jan 2025 | UK£2.0b | UK£306.9m | -UK£195,547,507.20 | 7.4x | -10.4x | 6.6x |
| Sun, 29 Dec 2024 | UK£1.8b | UK£306.6m | -UK£195,250,541.04 | 7.6x | -9.4x | 6x |
| Tue, 26 Nov 2024 | UK£1.9b | UK£306.6m | -UK£193,104,295.28 | 7.8x | -9.6x | 6.1x |
| Thu, 24 Oct 2024 | UK£2.0b | UK£304.8m | -UK£192,626,890.90 | 11.2x | -10.5x | 6.7x |
| Sat, 21 Sep 2024 | UK£2.2b | UK£303.8m | -UK£191,679,415.50 | 11.5x | -11.5x | 7.3x |
| Mon, 19 Aug 2024 | UK£1.9b | UK£296.2m | -UK£188,767,577.70 | 12.3x | -9.9x | 6.3x |
| Wed, 17 Jul 2024 | UK£1.7b | UK£295.1m | -UK£189,581,540.91 | 11.8x | -8.7x | 5.6x |
| Fri, 14 Jun 2024 | UK£1.6b | UK£295.5m | -UK£189,761,016.45 | 11.7x | -8.5x | 5.5x |
| Sun, 12 May 2024 | UK£1.7b | UK£295.1m | -UK£187,865,864.75 | 6797.2x | -8.9x | 5.6x |
| Tue, 09 Apr 2024 | UK£1.7b | UK£319.0m | -UK£191,315,873.91 | 69.6x | -8.7x | 5.2x |
| Thu, 07 Mar 2024 | UK£1.8b | UK£285.6m | -UK£189,049,492.55 | 6894x | -9.7x | 6.4x |
| Sat, 03 Feb 2024 | UK£2.8b | UK£450.4m | -UK£176,742,955.00 | 69.8x | -16x | 6.3x |
| Mon, 01 Jan 2024 | UK£3.2b | UK£449.9m | -UK£173,922,769.00 | 56.2x | -18.3x | 7.1x |
| Wed, 29 Nov 2023 | UK£3.0b | UK£455.2m | -UK£168,271,664.00 | 49.9x | -18x | 6.7x |
| Fri, 27 Oct 2023 | UK£2.9b | UK£458.8m | -UK£165,751,401.00 | 46.7x | -17.6x | 6.3x |
| Sun, 24 Sep 2023 | UK£3.1b | UK£447.9m | -UK£167,427,280.00 | 67.5x | -18.3x | 6.8x |
| Tue, 22 Aug 2023 | UK£3.1b | UK£476.1m | -UK£126,481,538.00 | 70.6x | -24.3x | 6.4x |
| Thu, 20 Jul 2023 | UK£3.3b | UK£476.1m | -UK£124,419,656.00 | 69.6x | -26.4x | 6.9x |
Price to Earnings Ratio
-26.4x
Current Industry PE
- Investors are pessimistic on the British Life Sciences Tools and Services industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The 3-year average PS ratio of 5.8x is higher than the industry's current PS ratio of 4.3x.
Past Earnings Growth
- The earnings for companies in the Life Sciences Tools and Services industry have deteriorated over the last three years.
- Revenues have also declined 12% per year.
- This means overall sales from these companies are declining and losses are subsequently expanding as well.
Industry Comparison
How does U.K. Clinical Research and Equipment compare with similar industries?
| GB Market | -1.66% | |
| Healthcare | -7.62% | |
| Life Sciences | -0.40% | |
| Clinical Research and Equipment | -0.40% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| IXI IXICO | UK£0.092 | 12.1% +UK£2.2m | -5.1% | PS2.8x | |
| PRM Proteome Sciences | UK£0.017 | 4.6% +UK£263.0k | -44.1% | PS1.6x |